Article -> Article Details
|Cardiovascular Needle Market Covers Global Industry Share, Size by 2023
|Fitness Health --> Health Insurance
|Cardiovascular Needle Market
The global cardiovascular
needle market, as Market Research Future (MRFR) suggests, can
attain 7.2% CAGR over the review period (2017-2023). Several treatments require
cardiovascular needles such as open-heart surgery, cardiac valve procedures,
coronary artery bypass graft surgery, heart transplant, and others. The need
for such needles is on the rise as cases related to cardiovascular diseases are
rising. This is due to a change in the lifestyle where urbanization has led to
irregular consumption habit, sedentary lifestyle, low physical activity, and
several other adverse features that can negatively impact the heart. At the
same time, the increasing aged population is also leading to the adoption of
such treatments. In addition, habits such as smoking and consumption of liquor
often lead to problems that can trigger health-issues and requirement of
cardiovascular surgeries. With advanced technologies, the cardiovascular
needles market is set to expand more in the coming years.
On the flip side, the cardiovascular needles market may
witness a dip in the sale due to the growing use of surgical staples. However,
cardiovascular needles have some specific utility where it can thrive more and
reach the expected market valuation in the coming years.
MRFR’s report on the global cardiovascular needle market is
segmented by types, application, by usage, and by the end user.
Based on the type, the cardiovascular needle market
comprises round bodied needles and cutting needles. The round-bodied needles segment
consists taper point needles and blunt point needles. The cutting needles
segment consists conventional cutting needles and reverses cutting needles.
Based on the application, the cardiovascular needle market consists
cardiac valve procedures, coronary artery bypass graft surgery, heart
transplant, open heart surgery, and others.
Based on the usage, the cardiovascular needle market
comprises single use and multiple uses.
Based on the end-user, the cardiovascular needle market can be
segmented into hospitals, clinics, ambulatory surgical centers, and others.
MRFR in their research on the cardiovascular needle market
founded on four regions, namely the Americas, Europe, Asia Pacific (APAC), and
the Middle East & Africa (MEA). The report also digs deep to provide a
volume-wise and value-wise segmentation of the market.
Several prevalent diseases such as diabetes, obesity,
cardiovascular irregularity, and others are present in the region in
substantial number due to which the market of America has grown substantially
strong. The regional market is getting amply backed by the superior
infrastructure of the healthcare and high investment capacity of the region for
research and development. Amply backed by the government and private funds, the
region is expected to secure its premier position for the coming years as well.
Europe ranks second in the global cardiovascular needle
market due to the presence of several market titans. However, these companies
are also involved in exporting their product to developing countries through
which they are earning much revenue.
APAC’s growth would be the fastest as predicted in the
report. It can be attributed to the presence of a large number of people in the
region who are suffering from cardiovascular diseases. The revamping of the
healthcare sector in these developing economies requires better quality
instruments owing to which the market is bound to grow during the forecast
However, the MEA market contributes the least due to low expenditure
in research and development activities and inferior healthcare infrastructure.
Players influencing the market are B. Braun Melsungen AG (Germany), CP
Medical, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), Ethicon Inc. (U.S.),
Sheffield Ltd. (U.K.), KLS Martin Group (U.S.), Scanlan International Inc. (U.S.),
Teleflex Incorporated (U.S.), Rumex International Corporation Ltd. (U.S.),
Sklar Surgical Instruments (U.S.), Surgins surgical Ltd. (U.K.), Surtex
Instruments Ltd. (U.K.), Medline Industries, Inc. (U.S.), Quality Needles Pvt.
Ltd. (India), Delacroix-Chevalier (France), Wexler Surgical (U.S.), Symmetry
Surgical Inc. (U.S.), Cardivon Surgical Inc. (China), FSSB Surgical Needles
GmbH (Germany), and others.